Continued Versus Discontinued Oxytocin Stimulation in the Active Phase of Labour (CONDISOX): Double Blind Randomized Controlled Trial. Issue 1 (23rd March 2022)

• Record Type: Journal Article
• Authors: Boie, S.; Glavind, J.; Uldbjerg, N.; Steer, P.J.; Bor, P.
• Is Part Of: Obstetric anesthesia digest. Volume 42:Issue 1(2022)
• Page Start: 24
• Page End: 25
• Publication Date: 2022-03-23
• Subjects: Obstetric Hemorrhage -- Pharmacology -- Systems Based Practice; Anesthesia in obstetrics -- Periodicals; Anesthesia in obstetrics -- Abstracts -- Periodicals; 617.968205
• DOI: 10.1097/01.aoa.0000816816.11042.9a
• Languages: English
• ISSNs: 0275-665X

Abstract

Abstract : ( BMJ . 2021;372:n716) Oxytocin is commonly used to stimulate the uterus and induce labor. Hyperstimulation carries risks to mother and fetus and may increase the likelihood of cesarean delivery (CD). Recent studies suggest that discontinuing oxytocin augmentation will not interrupt labor but may help avoid hyperstimulation. It is unclear if discontinuing oxytocin has an effect on the cesarean rate. This study aims to determine whether discontinuing oxytocin once labor is established reduces the cesarean rate.